Works matching IS 18696953 AND DT 2023 AND VI 14 AND IP 9


Results: 10
    1
    2
    3
    4
    5

    Overall Efficacy and Safety of Sodium-Glucose Cotransporter 2 Inhibitor Luseogliflozin Versus Dipeptidyl-Peptidase 4 Inhibitors: Multicenter, Open-Label, Randomized-Controlled Trial (J-SELECT study).

    Published in:
    Diabetes Therapy, 2023, v. 14, n. 9, p. 1517, doi. 10.1007/s13300-023-01438-w
    By:
    • Sugawara, Masahiro;
    • Fukuda, Masahiro;
    • Sakuma, Ichiro;
    • Wakasa, Yutaka;
    • Funayama, Hideaki;
    • Kondo, Akira;
    • Itabashi, Naoki;
    • Maruyama, Yasuyuki;
    • Kamiyama, Takashi;
    • Utsunomiya, Yasunori;
    • Yamauchi, Akira;
    • Yoshii, Hidenori;
    • Yamada, Hirokazu;
    • Mochizuki, Koichi;
    • Seino, Hiroaki;
    • Murata, Kaori;
    • Yatagai, Shigeo;
    • Koyama, Hiroshi;
    • Yamamoto, Hareaki;
    • Shimizu, Miho
    Publication type:
    Article
    6
    7
    8
    9
    10